A bioXriv preprint contends that a 2020 paper linking bacteria to cancer was based on flawed data analysis — Introduction In a bioRxiv preprint posted in July, which Derek Lowe compares to a ‘cruise missile’ on the data analyses employed in a 2020 paper, Gihawi et al. identifies two major data analysis flaws, each of which would have invalidated the 2020 paper’s findings. Poore et al. claimed in 2020 that…

13 drugs were approved by the FDA in the first quarter of 2023; 4 of them for rare diseases, 3 for cancers. Name — Active Ingredient — Disease Indication Leqembi — lecanemab-irmb — To treat Alzheimer’s disease Brenzavvy — bexagliflozin — To improve glycemic control in adults with type 2…